ITF Pharma Plans October US Roll-Out Of Liquid Riluzole Formulation For ALS

 
• By Emily Hayes

Early engagement with US payers suggests openness to covering a liquid form of riluzole, because the tablet version is proven, but it's impossible to take for many ALS patients, says Italfarmaco subsidiary ITF Pharma.

Red Approved Stamp with Wooden handle Rubber Stamper Isolated on White Background.

More from Rare Diseases

More from Scrip